Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
Adult; Aged; Female; Humans; Liver Neoplasms/secondary; Male; Medical Records; Middle Aged; Multiple Endocrine Neoplasia Type 1/diagnosis; Multivariate Analysis; Neoplasms, Second Primary/diagnosis; Odds Ratio; Pancreatic Neoplasms/pathology; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Zollinger-Ellison Syndrome/diagnosis
Abstract :
[en] BACKGROUND & AIMS: Risk factors of metachronous liver metastases and death are not well known in patients with the Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. These factors were retrospectively determined in 77 patients. METHODS: Data chart review was performed. RESULTS: Median follow-up was 102 months (range, 12-366). Surgery was performed on 48 patients, including 9 of the 10 patients with large pancreatic tumors (>/=3 cm). Liver metastases developed in 4 patients (40%) with large pancreatic tumors, in 3 (4.8%) without, and in 1 of the 4 patients with pancreatic tumors of unknown size; all had previously undergone surgery. The only independent factor associated with development of liver metastases identified by multivariate analysis was large pancreatic tumors (risk ratio, 29.0; 95% confidence interval [CI], 3. 2-260.7). Surgery was not selected. The probability of being free of liver metastases in the 63 patients without large pancreatic tumors was 96% (95% CI, 88-100) at 10 and 15 years. Thirteen (16.9%) patients died. The only independent factors of death selected by multivariate analysis were Zollinger-Ellison syndrome diagnosis before 1980 (risk ratio, 8.2; 95% CI, 1.7-40.6) and age at diagnosis (risk ratio/year, 1.08; 95% CI, 1.03-1.14). CONCLUSIONS: Large pancreatic tumors are predictive of the development of metachronous liver metastases, and surgery does not seem to prevent them.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Cadiot, G.
Vuagnat, A.
Doukhan, I.
Murat, A.
Bonnaud, G.
Delemer, B.
Thiefin, G.
Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Veyrac, M.
Proye, C.
Ruszniewski, P.
Mignon, M.
Language :
English
Title :
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
Publication date :
February 1999
Journal title :
Gastroenterology
ISSN :
0016-5085
eISSN :
1528-0012
Publisher :
W.B. Saunders, Philadelphia, United States - Pennsylvania
P Ruszniewski P Podevin G Cadiot JP Marmuse M Mignon C Vissuzaine S Bonfils T. Lehy Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia Pancreas 8 1993 295 304
HC Weber DJ Venzon J-T Lin VA Fishbein M Orbuch DB Strader F Gibril DC Metz DL Fraker JA Norton RT. Jensen Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study Gastroenterology 108 1995 1637 1649
DR Farley JA Van Heerden CS Grant LJ Miller DM. Ilstrup The Zollinger-Ellison syndrome. A collective surgical experience Ann Surg 215 1992 561 570
EC. Ellison Forty-year appraisal of gastrinoma. Back to the future Ann Surg 222 1995 511 524
WS Melvin JA Johnson J Sparks JT Innes EC. Ellison Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia Surgery 114 1993 1183 1188
F Stadil L Bardram J Gustafsen F. Efsen Surgical treatment of the Zollinger-Ellison syndrome World J Surg 17 1993 463 467
DL Fraker JA. Norton The role of surgery in the management of islet cell tumors Gastroenterol Clin North Am 4 1989 805 830
TJ Howard MP Sawicki BE Stabile PC Watt E. Passaro Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery Am J Surg 165 1993 101 106
EL Kaplan K Horvath A Udekwu F Straus C Schark DJ Ferguson DB. Skinner Gastrinomas: a 42-year experience World J Surg 14 1990 365 376
BE Stabile E. Passaro Benign and malignant gastrinoma Am J Surg 146 1985 144 150
C Donow M Pipeleers-Marichal S Schröder B Stamm PU Heitz G. Klöppel Surgical pathology of gastrinoma: site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy Cancer 68 1991 1329 1334
DL Fraker JA Norton HR Alexander DJ Venzon RT. Jensen Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma Ann Surg 220 1994 320 330
M Mignon G. Cadiot Gastrinomas (Zollinger-Ellison syndrome) J Howard Y Idezuki I Ihse R Prinz Surgical diseases of the pancreas. 1997 Williams & Wilkins Baltimore 733 744
JA. Norton Surgical treatment of islet cell tumors with special emphasis on operative ultrasound Front Gastrointest Res 23 1995 309 332
RT Jensen JD. Gardner Gastrinoma Second ed VLW Go EP DiMagno JD Gardner E Lebenthal HA Reber GA Scheele The pancreas: biology, pathobiology, and disease. 1993 Raven New York 931 978
M Mignon G Cadiot D Rigaud P Ruszniewski P Jaïs T Lehy MJM. Lewin The management of islet cell tumors in patients with multiple endocrine neoplasia type 1 (MEN 1) Front Gastrointest Res 23 1995 342 359
MP MacFarlane DL Fraker HR Alexander JA Norton I Lubensky RT. Jensen Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1 Surgery 118 1995 973 980
B Padberg S Schröder C Capella A Frilling G Klöppel PU. Heitz Multiple endocrine neoplasia type 1 (MEN 1) revisited Virchows Arch 426 1995 541 548
NW. Thompson The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patients J Intern Med 238 1995 269 280
BI. Hirschowitz Clinical course of nonsurgically treated Zollinger-Ellison syndrome Front Gastrointest Res 23 1995 360 371
JA Norton RT. Jensen Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome World J Surg 15 1991 151 159
B Skogseid D Grama J Rastad B Eriksson PG Lindgren H Ahlström LE Lörelius E Wilander G Akerström K. Öberg Operative tumour yield obviates preoperative pancreatic tumour localization in multiple endocrine neoplasia type 1 J Intern Med 238 1995 281 288
B Wiedenmann RT Jensen M Mignon CI Modlin B Skogseid G Doherty K. Öberg Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommandations by a consensus workshop World J Surg 22 1998 309 318
M Mignon P Jaïs G Cadiot J. Vatier Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome Front Gastrointest Res 23 1995 223 229
P Chanson G Cadiot A Murat 1. on behalf of GENEM Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1 Horm Res 47 1997 211 220
JF London TH Shawker JL Doppman HH Frucht R Vinayek HA Stark LS Miller DL Miller JA Norton RT Jensen JD Gardner PN. Maton Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas Radiology 178 1991 763 767
SA Wank JL Doppman DL Miller MJ Collen PN Maton R Vinayek JA Norton JD Gardner RT. Jensen Prospective study of the ability of computerized axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome Gastroenterology 92 1987 905 912
M Orbuch JL Doppman DB Strader VA Fishbeyn RV Benya DC Metz RT. Jensen Imaging for pancreatic endocrine tumor localization: recent advances Front Gastrointest Res 23 1995 268 281
B Skogseid B Eriksson G Lundqvist LE Lörelius J Rastad L Wide G Akerström K. Öberg Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds J Clin Endocrinol Metab 73 1991 281 287
L Palazzo E Borotto B Napoléon B Pujol G Roseau R Gimbaud JC Souquet S Chaussade D Couturier Y Chapuis JA. Paolaggi Is endoscopic ultrasonography accurate for the localization of pancreatic and duodenal tumors in patients with multiple endocrine neoplasia type 1 (abstr)? Gastroenterology 106 1994 A313
I Sobhani L Elouaer-Blanc T Lehy J Rahier S Pauwels M Mignon S Bonfils MJM. Lewin Immunohistochemical characterization of gastrinomas with antibodies specific to different fragments of progastrin Gastroenterol Clin Biol 13 1989 865 872
F Walker T Lehy D Bernuau I Sobhani D Bayle G Feldmann MJM. Lewin Detection of gastrin mRNA in human antral mucosa and digestive endocrine tumors by in situ hybridization: a correlative study with immunocytochemistry and electron microscopy J Histochem Cytochem 40 1992 1363 1372
R Delcore LY Cheung SR. Friesen Outcome of lymph node involvement in patients with Zollinger-Ellison syndrome Ann Surg 206 1988 291 298
S La Rosa F Sessa C Capella C Riva BE Leone C Klersy G Rindi E. Solcia Prognostic criteria in nonfunctioning pancreatic endocrine tumours Virchows Arch 429 1996 323 333
DC Metz M Kuchnio DL Fraker DJ Venzon G Jaffe RT Jensen M. Stetler-Stevenson Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course Gastroenterology 105 1993 799 813
P Ruszniewski P Amouyal G Amouyal G Cadiot M Mignon P. Bernades Endocrine tumors of the pancreatic area: localization by endoscopic ultrasonography Front Gastrointest Res 23 1995 258 267
B Eriksson K Öberg B. Skogseid Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients Acta Oncol 28 1989 373 377